Kathleen L O'Connor Selected Research

Ligands

1/2017	Integrin α6β4 Upregulates Amphiregulin and Epiregulin through Base Excision Repair-Mediated DNA Demethylation and Promotes Genome-wide DNA Hypomethylation.
8/2003	Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen L O'Connor Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 11/2003
10	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2008
6	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2005
6	Carcinoma (Carcinomatosis) 01/2016 - 01/2009
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 08/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2016
4	Adenocarcinoma 01/2016 - 06/2007
3	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 06/2014 - 01/2007
2	Carcinogenesis 05/2011 - 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Neuroblastoma 12/2012
1	Colonic Neoplasms (Colon Cancer) 05/2011
1	Lymphoma (Lymphomas) 05/2008
1	Chronic Pancreatitis 06/2007
1	Inflammation (Inflammations) 01/2007

Drug/Important Bio-Agent (IBA)

8	IntegrinsIBA 01/2017 - 11/2003
4	Integrin alpha6beta4IBA 01/2009 - 07/2005
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2015
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2015 - 05/2008
3	Transcription Factors (Transcription Factor)IBA 09/2015 - 08/2003
3	lysophosphatidic acidIBA 10/2013 - 05/2007
2	LigandsIBA 01/2017 - 08/2003
2	Calcibiotic Root Canal SealerIBA 06/2014 - 05/2011
2	matrigelIBA 06/2014 - 11/2003
2	NeurotensinIBA 01/2007 - 07/2004
2	Peptides (Polypeptides)IBA 01/2007 - 07/2004
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	PlatinumIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Neuropilin-1IBA 01/2019
1	HexokinaseIBA 01/2019
1	S100 Calcium-Binding Protein A4IBA 01/2019
1	EpiregulinIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	AmphiregulinIBA 01/2017
1	Niclosamide FDA Link 06/2016
1	Growth Factor ReceptorsIBA 01/2016
1	Laminin ReceptorsIBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 11/2015
1	AntibodiesIBA 11/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2014
1	EnzymesIBA 06/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	geraniol (nerol)IBA 01/2014
1	prenylIBA 01/2014
1	FarnesolIBA 01/2014
1	Terpenes (Terpenoids)IBA 01/2014
1	Monomeric GTP-Binding ProteinsIBA 01/2014
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2014
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 10/2013
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 10/2013
1	Bombesin Receptors (Bombesin Receptor)IBA 12/2012
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 05/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2011
1	src-Family KinasesIBA 05/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2011
1	thiazolyl blueIBA 05/2011
1	Rapamycin-Insensitive Companion of mTOR ProteinIBA 05/2011
1	Messenger RNA (mRNA)IBA 05/2011
1	Phosphotransferases (Kinase)IBA 05/2011
1	CollagenIBA 02/2009
1	laminin 1IBA 02/2009
1	ChromatinIBA 01/2009
1	NucleotidesIBA 05/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2007
1	Lysophosphatidic Acid ReceptorsIBA 05/2007
1	Dinoprostone (PGE2)FDA Link 01/2007
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 07/2005
1	Butyrates (Butyrate)IBA 11/2003
1	Ribonucleases (Ribonuclease)IBA 11/2003
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2003
1	PPAR gammaIBA 08/2003

Therapy/Procedure

2	Therapeutics 06/2016 - 01/2014
1	Drug Therapy (Chemotherapy) 01/2019